Stock Scorecard
Stock Summary for Soleno Therapeutics Inc (SLNO) - $53.62 as of 9/12/2025 9:26:21 PM EST
Total Score
6 out of 30
Safety Score
45 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SLNO
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SLNO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SLNO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SLNO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for SLNO (45 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for SLNO
Financial Details for SLNO
Company Overview |
|
|---|---|
| Ticker | SLNO |
| Company Name | Soleno Therapeutics Inc |
| Country | USA |
| Description | Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of rare diseases. The company is headquartered in Redwood City, California. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/5/2025 |
Stock Price History |
|
| Last Day Price | 53.62 |
| Price 4 Years Ago | 6.15 |
| Last Day Price Updated | 9/12/2025 9:26:21 PM EST |
| Last Day Volume | 3,124,202 |
| Average Daily Volume | 1,716,484 |
| 52-Week High | 90.32 |
| 52-Week Low | 41.50 |
| Last Price to 52 Week Low | 29.20% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.34 |
| Sector PE | 40.86 |
| 5-Year Average PE | -21.26 |
| Free Cash Flow Ratio | 37.24 |
| Industry Free Cash Flow Ratio | 13.20 |
| Sector Free Cash Flow Ratio | 29.37 |
| Current Ratio Most Recent Quarter | 15.13 |
| Total Cash Per Share | 1.44 |
| Book Value Per Share Most Recent Quarter | 4.76 |
| Price to Book Ratio | 13.28 |
| Industry Price to Book Ratio | 28.96 |
| Sector Price to Book Ratio | 32.27 |
| Price to Sales Ratio Twelve Trailing Months | 97.67 |
| Industry Price to Sales Ratio Twelve Trailing Months | 44.01 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.72 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 53,145,000 |
| Market Capitalization | 2,849,634,900 |
| Institutional Ownership | 110.24% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -351.04% |
| Reported EPS 12 Trailing Months | -4.22 |
| Reported EPS Past Year | -1.04 |
| Reported EPS Prior Year | -4.26 |
| Net Income Twelve Trailing Months | -181,079,000 |
| Net Income Past Year | -175,850,000 |
| Net Income Prior Year | -38,988,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -16.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 76,497,000 |
| Total Cash Past Year | 87,928,000 |
| Total Cash Prior Year | 169,681,000 |
| Net Cash Position Most Recent Quarter | 26,652,000 |
| Net Cash Position Past Year | 38,100,000 |
| Long Term Debt Past Year | 49,828,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 49,845,000 |
| Equity to Debt Ratio Past Year | 0.83 |
| Equity to Debt Ratio Most Recent Quarter | 0.83 |
| Total Stockholder Equity Past Year | 245,113,000 |
| Total Stockholder Equity Prior Year | 157,507,000 |
| Total Stockholder Equity Most Recent Quarter | 240,140,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -84,490,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.59 |
| Free Cash Flow Past Year | -69,314,000 |
| Free Cash Flow Prior Year | -24,940,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -3.16 |
| MACD Signal | -3.30 |
| 20-Day Bollinger Lower Band | 61.87 |
| 20-Day Bollinger Middle Band | 76.99 |
| 20-Day Bollinger Upper Band | 92.11 |
| Beta | -2.72 |
| RSI | 32.62 |
| 50-Day SMA | 62.63 |
| 150-Day SMA | 36.04 |
| 200-Day SMA | 28.08 |
System |
|
| Modified | 9/11/2025 10:02:40 AM EST |